Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP001147

Drug Information
NameBenzphetamine
SynonymsCID2341; Benzeneethanamine, N,alpha-dimethyl-N-(phenylmethyl)-; (alphaS)-N,alpha-dimethylphenethylamine; DB00865; Benzfetamina [Spanish]; d-Benzphetamine; MolPort-002-051-901; benzaphetamine; N-benzyl-N-methyl-1-phenylpropan-2-amine; BRN 3203999; Benzeneethanamine, N,alpha-dimethyl-N-(phenylmethyl)-, (S)-; Benzfetaminum; DEA No. 1228; CID5311017; Benzfetamine; Benzfetaminum [Latin]; N-Benzylmethamphetamin; N,alpha-Dimethyl-N-(phenylmethyl)-benzeneethanamine; Benzeneethanamine, N,alpha-dimethyl-N-(phenylmethyl)-, (+)- (9CI); AC1NSJU8; (S)-benzphetamine; Benzfetamina [INN-Spanish]; L000849; N-Benzyl-N-methyl-1-phenyl-2-propanamine; AC1L1DGO; Phenethylamine, N-benzyl-N,.alpha.-dimethyl-, (+)-; N-methyl-1-phenyl-N-(phenylmethyl)propan-2-amine; LS-103107; (2S)-N-benzyl-N-methyl-1-phenylpropan-2-amine; Phenethylamine, N-benzyl-N,alpha-dimethyl-, (+)-; (+)-N,alpha-dimethyl-N-(phenylmethyl)-benzeneethanamine; CPD-10530; C17H21N; C07538; (S)-(+)-N-benzyl-N,alpha-dimethylphenethylamine; LS-187200; HSDB 3294; Benzfetamine [INN:BAN]; Benzofetamina [INN-Spanish]; Benzfetamina; Benzeneethanamine, N,alpha-dimethyl-N-(phenylmethyl)-, (+)-; Benzfetamine (INN); 156-08-1; (S)-(+)-benzphetamine; Benzphetaminum; D07514; N,alpha-Dimethyl-N-(phenylmethyl)benzeneethanamine; Benzphetaminum [INN-Latin]; benzphetamine; (+)-N-benzyl-N,alpha-dimethylphenethylamine; U 0441; CHEBI:3044; D-N-Methyl-N-benzyl-beta-phenylisopropylamine; Benzfetamina [DCIT]; Benzylamphetamine; Benzeneethanamine, N,.alpha.-dimethyl-N-(phenylmethyl)-, (+)-; (+)-benzphetamine; Benzfetaminum [INN-Latin]; UNII-0M3S43XK27; Benzofetamina; (R,S)-N-Benzyl-alpha,N-dimethylphenethylamin; 101-47-3; N-Benzyl-N,alpha-dimethylphenethylamine
Trade NameDidrex
CompanyPharmacia
IndicationObesity
[ICD9: 278   ICD10: E66]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C17H21N/c1-15(13-16-9-5-3-6-10-16)18(2)14-17-11-7-4-8-12-17/h3
-12,15H,13-14H2,1-2H3/t15-/m0/s1
InChIKeyYXKTVDFXDRQTKV-HNNXBMFYSA-N
Canonical SMILESCC(CC1=CC=CC=C1)N(C)CC2=CC=CC=C2    
Isomeric SMILESC[C@@H](CC1=CC=CC=C1)N(C)CC2=CC=CC=C2
Therapeutic ClassAdrenergic Agents
CAS NumberCAS 156-08-1
FormulaC17H21N
PubChem Compound IDCID 5311017.
PubChem Substance IDSID 7978770.
TargetN-methyl-D-aspartate (NMDA) receptorAntagonist[2]
Ref 1Obesity: pathophysiology and clinical management. Curr Med Chem. 2009;16(4):506-21. To Reference
Ref 2J Pharmacol Exp Ther. 2002 Mar;300(3):1008-16.Amphetamine inhibits the N-methyl-D-aspartate receptor-mediated responses by directly interacting with the receptor/channel complex. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543